
Kymera Therapeutics (KYMR) Earnings Dates & Reports
Kymera Therapeutics (KYMR) Most Recent Earnings
Report DateAug 11, 2025
Period EndingQ2 2025
Est. EPS-$0.77
Actual EPS-$0.95
EarningsMiss
Kymera Therapeutics (KYMR) Earnings
View the latest Kymera Therapeutics (KYMR) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Kymera Therapeutics (KYMR)
Order type
Buy in
Order amount
Est. shares
0 shares
Kymera Therapeutics (KYMR) Earnings per Share (EPS) History
Signup for full accessBrowse free
Kymera Therapeutics (KYMR) Latest Earnings
The value each KYMR share was expected to gain vs. the value each share gained.
Kymera Therapeutics (KYMR) reported its most recent earnings on Aug 11, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.95. This exceeded analysts' expectations of -$0.77 by 23.38%, marking a Miss.
For comparison, Kymera Therapeutics reported EPS of -$0.58 in the same quarter last year.
The company is expected to announce its next earnings report on 10/30/2025, with analysts projecting an EPS of -$0.78.
Kymera Therapeutics (KYMR) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q3 2025Oct 30, 2025 | -$0.78 | Next earnings call Oct. 30, 2025 | ||
Q2 2025Aug 11, 2025 | -$0.77 | -$0.95 | +23.38% | |
Q1 2025May 9, 2025 | -$0.91 | -$0.82 | -9.89% | |
Q4 2024Feb 27, 2025 | -$0.79 | -$0.88 | +11.39% | |
Q3 2024Oct 31, 2024 | -$0.84 | -$0.82 | -2.38% | |
Kymera Therapeutics (KYMR) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Kymera Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 11, 2025 | — | — | — |
May 9, 2025 | — | — | — |
Feb 27, 2025 | — | — | — |
Oct 31, 2024 | — | — | — |
Kymera Therapeutics (KYMR) Earnings FAQs
Kymera Therapeutics (KYMR) last reported earnings on Aug 11, 2025 for Q2 2025, posting an EPS of -$0.95, which Miss the estimate of -$0.77 by 23.38%.
For Q2 2025, Kymera Therapeutics (KYMR) reported an EPS of -$0.95, missing analysts' estimate of -$0.77 by 23.38%.
For Q2 2025, Kymera Therapeutics (KYMR) Miss expectations with an actual EPS of -$0.95 vs. an estimated EPS of -$0.77.
Following the last earnings report on Aug 11, 2025, Kymera Therapeutics (KYMR)'s stock price moved — from — to —.
The next Kymera Therapeutics (KYMR) earnings call is scheduled for Oct. 30, 2025, where executives will discuss financial results and outlook.